Status:
COMPLETED
MAC Project, Monitoring of AntiCoagulant Therapies (MAC)
Lead Sponsor:
Quovadis Associazione
Conditions:
Anticoagulants and Bleeding Disorders
Eligibility:
All Genders
18+ years
Brief Summary
MAC Project is a prospective cohort, multicenter, observational, no-profit study aimed to prospectively collect reliable real-life clinical information in unselected VTE or NVAF patients treated with ...
Detailed Description
MAC Project is a prospective cohort, multicenter, observational, no-profit study aimed to prospectively collect reliable real-life clinical information in unselected VTE or NVAF patients treated with ...
Eligibility Criteria
Inclusion
- aged \> 18 years,
- mandatory anticoagulant treatment
- ability to understand the purposes of the study
- ability to express valid informed consent.
Exclusion
- none
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04329390
Start Date
March 1 2019
End Date
December 1 2024
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Giuseppe Camporese
Padua, Italy, 35138